ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Medical Devices Global Blood Purification Equipment Market Size, Demand, Report to 2032
Blood Purification Equipment Market

Blood Purification Equipment Market Size, Share & Trends Analysis Report By Product (Portable, Stationary), By Procedure (Dialysis, Continuous Renal Replacement Therapy (CRRT), Hemoperfusion, Others), By Indication (Sepsis, Renal Diseases, Others), By End User (Hospitals and Clinics, Dialysis Centers, Homecare Settings, Others), By Type (Dialysis, CRRT, Hemoperfusion, Others (Plasma Exchange and Immunoadsorption)) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD2582DR
Author : ÀºÇòÅâÂÊ
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Blood Purification Equipment Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Portable
        1. By Value
      3. Stationary
        1. By Value
    3. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Dialysis
        1. By Value
      3. Continuous Renal Replacement Therapy (CRRT)
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Sepsis
        1. By Value
      3. Renal Diseases
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
      5. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Dialysis
        1. By Value
      3. CRRT
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others (Plasma Exchange and Immunoadsorption)
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Portable
        1. By Value
      3. Stationary
        1. By Value
    3. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Dialysis
        1. By Value
      3. Continuous Renal Replacement Therapy (CRRT)
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Sepsis
        1. By Value
      3. Renal Diseases
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
      5. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Dialysis
        1. By Value
      3. CRRT
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others (Plasma Exchange and Immunoadsorption)
        1. By Value
    7. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Portable
          1. By Value
        3. Stationary
          1. By Value
      2. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Dialysis
          1. By Value
        3. Continuous Renal Replacement Therapy (CRRT)
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Sepsis
          1. By Value
        3. Renal Diseases
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
        5. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Dialysis
          1. By Value
        3. CRRT
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others (Plasma Exchange and Immunoadsorption)
          1. By Value
    8. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Portable
        1. By Value
      3. Stationary
        1. By Value
    3. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Dialysis
        1. By Value
      3. Continuous Renal Replacement Therapy (CRRT)
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Sepsis
        1. By Value
      3. Renal Diseases
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
      5. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Dialysis
        1. By Value
      3. CRRT
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others (Plasma Exchange and Immunoadsorption)
        1. By Value
    7. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Portable
          1. By Value
        3. Stationary
          1. By Value
      2. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Dialysis
          1. By Value
        3. Continuous Renal Replacement Therapy (CRRT)
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Sepsis
          1. By Value
        3. Renal Diseases
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
        5. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Dialysis
          1. By Value
        3. CRRT
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others (Plasma Exchange and Immunoadsorption)
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Portable
        1. By Value
      3. Stationary
        1. By Value
    3. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Dialysis
        1. By Value
      3. Continuous Renal Replacement Therapy (CRRT)
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Sepsis
        1. By Value
      3. Renal Diseases
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
      5. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Dialysis
        1. By Value
      3. CRRT
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others (Plasma Exchange and Immunoadsorption)
        1. By Value
    7. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Portable
          1. By Value
        3. Stationary
          1. By Value
      2. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Dialysis
          1. By Value
        3. Continuous Renal Replacement Therapy (CRRT)
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Sepsis
          1. By Value
        3. Renal Diseases
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
        5. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Dialysis
          1. By Value
        3. CRRT
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others (Plasma Exchange and Immunoadsorption)
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Portable
        1. By Value
      3. Stationary
        1. By Value
    3. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Dialysis
        1. By Value
      3. Continuous Renal Replacement Therapy (CRRT)
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Sepsis
        1. By Value
      3. Renal Diseases
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
      5. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Dialysis
        1. By Value
      3. CRRT
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others (Plasma Exchange and Immunoadsorption)
        1. By Value
    7. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Portable
          1. By Value
        3. Stationary
          1. By Value
      2. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Dialysis
          1. By Value
        3. Continuous Renal Replacement Therapy (CRRT)
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Sepsis
          1. By Value
        3. Renal Diseases
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
        5. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Dialysis
          1. By Value
        3. CRRT
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others (Plasma Exchange and Immunoadsorption)
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Portable
        1. By Value
      3. Stationary
        1. By Value
    3. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Dialysis
        1. By Value
      3. Continuous Renal Replacement Therapy (CRRT)
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Sepsis
        1. By Value
      3. Renal Diseases
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
      5. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Dialysis
        1. By Value
      3. CRRT
        1. By Value
      4. Hemoperfusion
        1. By Value
      5. Others (Plasma Exchange and Immunoadsorption)
        1. By Value
    7. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Portable
          1. By Value
        3. Stationary
          1. By Value
      2. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Dialysis
          1. By Value
        3. Continuous Renal Replacement Therapy (CRRT)
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Sepsis
          1. By Value
        3. Renal Diseases
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
        5. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Dialysis
          1. By Value
        3. CRRT
          1. By Value
        4. Hemoperfusion
          1. By Value
        5. Others (Plasma Exchange and Immunoadsorption)
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Blood Purification Equipment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Infomed SA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Braun Melsungen AG
    3. Baxter International Inc.
    4. Nikkiso Co.Ltd
    5. Jafron Biomedical Co.Ltd.
    6. SWS Hemodialysis Co.,ltd
    7. Fresenius SE & Co. KGaA
    8. Kaneka Corporation
    9. ExThera Medical Corporation
    10. Baihe Medical
    11. Cytosorbents Corporation
    12. Marker Therapeutics AG
    13. Medica S.p.A.
    14. Dialife SA
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market OverviewSterilization is a physical or chemical process that effectively kills or eliminates microorganisms and pathogens such as fungi, bacteria, viruses, and prions from food, equipment, or medication. The objective of food sterilization equ
Buy Now
Global Report
Rehabilitation Equipment Market Size The global rehabilitation equipment market size was valued at USD 22.04 billion in 2024 and is projected to grow from USD 23.98 billion in 2025 to reach USD 39.63 billion by 2033, exhibit
Buy Now
Global Report
Sterilization Equipment Market Size The global sterilization equipment market size was valued at USD 7.71 billion in 2024 and is projected to reach from USD 8.57 billion in 2025 to USD 19.88 billion by 2033, growing at a CAGR of 11.10% during the fo
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.